Literature DB >> 7606353

Effect of inhibition of nitric oxide synthesis on the uptake of LDL and fibrinogen by arterial walls and other organs of the rat.

L E Cardona-Sanclemente1, G V Born.   

Abstract

1. The effects of administering 3 mg ml-1 NG-nitro-L-arginine methyl ester (L-NAME), an inhibitor of nitric oxide (NO), on the uptake of low density lipoprotein (LDL), fibrinogen and blood pressure were determined in conscious, unrestrained, cannulated normotensive and spontaneously hypertensive (SHR) Wistar rats. 2. The uptake of LDL and fibrinogen, labelled respectively with 125I or 131I via the adduct tyramine cellobiose ([125I]TC-LDL and [131I]TC-fibrinogen), were compared in aortic walls, heart, skeletal muscle, lung, liver, kidney and adrenal during the final 24 h of 6 days' administration of L-NAME in the drinking water. 3. In control normotensive rats, the systolic blood pressure did not change significantly over 6 days, while administration of L-NAME in normotensive rats increased the blood pressure progressively and significantly to about 170 mmHg over the same period. 4. In normotensive rats L-NAME increased significantly the uptake of both LDL and fibrinogen by aortic walls and heart, but not by muscle, lung, liver, kidney and adrenal. 5. The blood pressure in SHR was about 170 mmHg before administration of L-NAME and did not increase significantly after 6 days of treatment. In these rats the uptake of LDL or of fibrinogen was increased only in the heart but not in aortic walls nor in any of the other organs. 6. In normotensive rats the increase in blood pressure caused by inhibition of NO generation was associated with increases in the uptake of the atherogenic plasma proteins LDL and fibrinogen by the wall of the aorta and by the heart but not by the skeletal muscle, lung, liver, kidney and adrenal. The slightly higher blood pressure of SHR treated with L-NAME was not associated with increased uptake of LDL or fibrinogen by aorta nor by any organ except heart. Thus, while in normotensive rats the increase in blood pressure caused by inhibition of NO generation was associated with increase in the uptake of atherogenic plasma proteins LDL and fibrinogen by the wall of the aorta and by the heart, in SHR which showed uptakes similar to the normotensive animals, the non-significant increase in blood pressure induced by inhibition of NO generation was not associated with increased uptake of LDL or fibrinogen in any organ except the heart.7. These results are consistent with effects, demonstrated earlier, of infusing the pressor agents noradrenaline, adrenaline and angiotensin II, which produce increases in uptake of LDL and fibrinogen by aortic wall, whereas this is not so in spontaneously hypertensive rats.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7606353      PMCID: PMC1510301          DOI: 10.1111/j.1476-5381.1995.tb13375.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  17 in total

1.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

Authors:  R J HAVEL; H A EDER; J H BRAGDON
Journal:  J Clin Invest       Date:  1955-09       Impact factor: 14.808

2.  Metabolic heterogeneity in the formation of low density lipoprotein from very low density lipoprotein in the rat: evidence for the independent production of a low density lipoprotein subfraction.

Authors:  N H Fidge; P Poulis
Journal:  J Lipid Res       Date:  1978-03       Impact factor: 5.922

Review 3.  The role of lipoproteins in steroidogenesis and cholesterol metabolism in steroidogenic glands.

Authors:  J T Gwynne; J F Strauss
Journal:  Endocr Rev       Date:  1982       Impact factor: 19.871

4.  In vivo and in vitro catabolism of native and biologically modified LDL.

Authors:  J F Nagelkerke; L Havekes; V W van Hinsbergh; T J van Berkel
Journal:  FEBS Lett       Date:  1984-06-04       Impact factor: 4.124

5.  A radioiodinated, intracellularly trapped ligand for determining the sites of plasma protein degradation in vivo.

Authors:  R C Pittman; T E Carew; C K Glass; S R Green; C A Taylor; A D Attie
Journal:  Biochem J       Date:  1983-06-15       Impact factor: 3.857

6.  Increased uptake of circulating low-density lipoproteins and fibrinogen by arterial walls after removal of sialic acids from their endothelial surface.

Authors:  P Görög; G V Born
Journal:  Br J Exp Pathol       Date:  1982-08

7.  Cholesterol metabolism in the genetically hypercholesterolemic (RICO) rat. II. A study of plasma lipoproteins and effect of dietary cholesterol.

Authors:  L E Cardona-Sanclemente; J Ferezou; C Lutton
Journal:  Biochim Biophys Acta       Date:  1988-06-15

8.  Isolation and properties of lipoproteins from normal rat serum.

Authors:  S Koga; D L Horwitz; A M Scanu
Journal:  J Lipid Res       Date:  1969-09       Impact factor: 5.922

9.  Fibrinogen as a risk factor for stroke and myocardial infarction.

Authors:  L Wilhelmsen; K Svärdsudd; K Korsan-Bengtsen; B Larsson; L Welin; G Tibblin
Journal:  N Engl J Med       Date:  1984-08-23       Impact factor: 91.245

10.  Visualization of the binding, endocytosis, and transcytosis of low-density lipoprotein in the arterial endothelium in situ.

Authors:  E Vasile; M Simionescu; N Simionescu
Journal:  J Cell Biol       Date:  1983-06       Impact factor: 10.539

View more
  5 in total

Review 1.  Endothelial nitric oxide synthase in the microcirculation.

Authors:  Xiaohong Shu; T C Stevenson Keller; Daniela Begandt; Joshua T Butcher; Lauren Biwer; Alexander S Keller; Linda Columbus; Brant E Isakson
Journal:  Cell Mol Life Sci       Date:  2015-08-25       Impact factor: 9.261

2.  Increase by adrenaline or angiotensin II of the accumulation of low density lipoprotein and fibrinogen by aortic walls in unrestrained conscious rats.

Authors:  L E Cardona-Sanclemente; G V Born
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

3.  Clusterin facilitates in vivo clearance of extracellular misfolded proteins.

Authors:  Amy R Wyatt; Justin J Yerbury; Paula Berghofer; Ivan Greguric; Andrew Katsifis; Christopher M Dobson; Mark R Wilson
Journal:  Cell Mol Life Sci       Date:  2011-04-20       Impact factor: 9.261

Review 4.  Molecular mechanisms responsible for the atheroprotective effects of laminar shear stress.

Authors:  Shi Pan
Journal:  Antioxid Redox Signal       Date:  2009-07       Impact factor: 8.401

5.  Activation of the peroxisome proliferator-activated receptor alpha protects against myocardial ischaemic injury and improves endothelial vasodilatation.

Authors:  Antonia Tabernero; Kristina Schoonjans; Laurence Jesel; Irina Carpusca; Johan Auwerx; Ramaroson Andriantsitohaina
Journal:  BMC Pharmacol       Date:  2002-04-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.